Close
Nordic 9Nordic 9

Novartis Venture Fund (investor - Corporate Investor)

Switzerland nvfund.com
See something wrong or missing? Let us know
Offices:Basel

Novartis Venture Funds is a private equity and venture capital arm of Novartis AG specializing in stage agnostic investments (seed to commercial companies)  in Biotechnology/Biopharma life sciences companies from multiple therapeutic areas where there is clear unmet medical need.

Average round investment:54.2M USD
Average number per year:3.2
Distribution: 2025 (5)2024 (5)2023 (3)2022 (4)2021 (4) See the entire list
Portfolio companies: Switzerland FoRxUnited Kingdom Artios PharmaUnited Kingdom NRG Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (8) Health services (25)
See the entire list

Showing 3 of 26 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Novartis Venture Fund mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Novartis Venture Fund

Name Criteria
France LBO France
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Spain
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
United States Morgan Stanley
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Finland, Ireland
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
France Orange Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Norway Hadean Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Spain, Netherlands, Finland
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United Kingdom Aviva Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
France C4Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Germany Yabeo
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Spain
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Felicis Ventures
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Spain, Netherlands, Finland, Ireland
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
Austria 3VC
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
Netherlands Prosus Ventures
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Spain, Netherlands, Finland, Ireland
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
Top